Meet Acticor Biotech team in Paris on July 1st, 2014

Acticor Biotech team will be available for discussion from 4:00 pm to 8:00 pm in the premises of its former incubator Agoranov in Paris to present the company and answer your questions.

Meet Acticor Biotech team

A company dedicated to the development of an innovative,
safe and effective treatment of ischemic stroke

Tuesday July 1st, starting 4 pm
Location : Agoranov incubator
96 bis Boulevard Raspail
75 006 Paris

Contact us here

Read next in 'Press Releases'

• Acticor Biotech Announces the Completion of Enrollment in its GARDEN clinical trial, a COVID-19-induced Acute Respiratory Distress Syndrome Efficacy Study
• Acticor Biotech Announces the Completion of Enrollment in ACTIMIS, its Key Phase 1b/2a Safety Study
• Acticor Biotech Announces appointment of Mr Alain Munoz as Chairman of the Board of Directors and Mrs Sophie Binay and Mr Yannick Pletan as General Managers
• Acticor Biotech Announces the Recruitment of the First Patient in its Phase 2 GARDEN Study in COVID-19_related ARDS
• Acticor Biotech Announces the Success of the First Phase of its ACTIMIS study with Glenzocimab In Patients with Acute Ischemic Stroke